Compugen

+$0.04 (+0.90%) As of 3:17 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Compugen and other ETFs, options, and stocks.

About CGEN

Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases.

CEO
Anat Cohen-Dayag
Employees
68
Headquarters
Holon, Tel Aviv
Founded
1993

CGEN Key Statistics

Market cap
375.25M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.11M
High today
$4.53
Low today
$4.31
Open price
$4.47
Volume
138.64K
52 Week high
$15.16
52 Week low
$3.68

CGEN Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 24, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure